Article
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
Molecular cancer - 7 Apr 2008
Wright Mollie H, Robles Ana I, Herschkowitz Jason I, Hollingshead Melinda G, Anver Miriam R, Perou Charles M, Varticovski Lyuba
Abstract excerpt
BACKGROUND: Development of therapies for patients with BRCA1 mutations has been hampered by lack of readily available in vitro and in vivo models. We recently showed that transplantation of transgenic mammary tumors as cell suspensions into naïve recipients generates reproducible tumors with remarkable stability of gene expression profile. We examined the expression profiles of original and serially transplanted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
